S

Selvita SA
WSE:SLV

Watchlist Manager
Selvita SA
WSE:SLV
Watchlist
Price: 48.7 PLN 3.07% Market Closed
Market Cap: 894.1m PLN
Have any thoughts about
Selvita SA?
Write Note

Selvita SA
Investor Relations

Selvita SA engages in the discovery, regulatory studies, as well as research and development. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 878 full-time employees. The company went IPO on 2019-10-16. The firm is engaged in providing multidisciplinary solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development. The company offers its clients drug discovery support at every stage of the early discovery phase up to preclinical research, from target validation up to the selection of a clinical candidate. Also, it offers services at every stage of the drug discovery process in the field of drug testing and bioanalytical analyses, from development and validation of methods, stability studies, to routine quality control testing. The firm cooperates with numerous research institutes and universities from Europe and the United States.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Boguslaw Stanislaw Sieczkowski M.B.A.
Chairman of Management Board & CEO
No Bio Available
Dr. Milosz Kazimierz Gruca Ph.D.
Chief Commercial Officer, Executive VP & Vice President of Management Board
No Bio Available
Mr. Dariusz Tomasz Kurdas
CFO & Member of the Management Board
No Bio Available
Dr. Miroslawa Monika Zydron Ph.D.
COO & Member of the Management Board
No Bio Available
Mr. Dawid Patryk Radziszewski
General Counsel & Member of the Management Board
No Bio Available
Dr. Adrijana Vinter
Global Head of Drug Discovery & Member of the Management Board
No Bio Available

Contacts

Address
WOJ. MALOPOLSKIE
Krakow
Park Life Science, ul. Bobrzynskiego 14
Contacts
+48122974700
selvita.com